Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Recipharm Venture Fund

Corporate VC Stockholm County, Sweden ·Founded 2015

Overview

Recipharm Venture Fund is a corporate venture capital fund established by Recipharm AB, a leading global Contract Development and Manufacturing Organisation (CDMO) headquartered in Sweden. The fund focuses on early-stage investments in pharmaceutical and biotech companies, aiming to support innovative ventures that align with Recipharm's strategic interests. The fund's investment strategy emphasizes sectors such as biotechnology, healthcare, medical devices, life sciences, pharmaceuticals, and clinical trials. It primarily targets early-stage ventures, providing capital and strategic support to foster growth and development in these industries. Recipharm Venture Fund has made notable investments, including a Series A funding round for NewBiologix in May 2023, and a venture round for Cinclus Pharma in March 2020. These investments reflect the fund's commitment to advancing healthcare innovations and its strategic focus on sectors that complement Recipharm's core business operations.

Investment Focus

Innovative pharmaceutical or biotech solutions
Alignment with Recipharm's strategic interests
Early-stage ventures with growth potential

Portfolio Companies

Cinclus PharmaNewBiologix

Reach Recipharm Venture Fund directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Recipharm Venture Fund

What sectors does Recipharm Venture Fund invest in?

Recipharm Venture Fund invests in Healthcare, Biotechnology, Pharmaceutical, Life Science, Clinical Trials and Medical, and is based in Stockholm County, Sweden. Recipharm Venture Fund is listed as a corporate vc in the ConnectSafely investor database.